Search research articles
Contact Us
Filters
Showing results (1-10 of 89) with videos related to
Page
of 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 9, 2010
DNA damage and repair in translational oncology: an overview
Eddie Reed
The New England Journal of Medicine
|
September 8, 2006
ERCC1 measurements in clinical oncology
Eddie Reed
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2005
ERCC1 and clinical resistance to platinum-based therapy
Eddie Reed
The West Virginia Medical Journal
|
February 13, 2004
Breast and ovarian cancer genetics and prevention
Ramin Altaha, Eddie Reed, Jame Abraham
Oncology Reports
|
October 20, 2004
Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review)
Gangduo Wang, Eddie Reed, Qingdi Q Li
International Journal of Molecular Medicine
|
April 6, 2006
Protein phosphatase 2A interacts with Chk2 and regulates phosphorylation at Thr-68 after cisplatin treatment of human ovarian cancer cells
Xiaobing Liang, Eddie Reed, Jing Jie Yu
International Journal of Molecular Medicine
|
June 18, 2004
Apoptosis in prostate cancer: progressive and therapeutic implications (Review)
Gangduo Wang, Eddie Reed, Qingdi Q Li
Cancer Research
|
May 8, 2007
A Gynecologic Oncology Group study of platinum-DNA adducts and excision repair cross-complementation group 1 expression in optimal, stage III epithelial ovarian cancer treated with platinum-taxane chemotherapy
Kathleen M Darcy, Chunqiao Tian, Eddie Reed
Oncology Reports
|
June 14, 2014
Gli1 contributes to cellular resistance to cisplatin through altered cellular accumulation of the drug
Lauren Amable, Jason Fain, Elaine Gavin, et al.
Current Pharmaceutical Design
|
August 13, 2002
Epothilones: a novel class of non-taxane microtubule-stabilizing agents
Ramin Altaha, Tito Fojo, Eddie Reed, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 89) with videos related to
Sort By:
Page
of 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 9, 2010
DNA damage and repair in translational oncology: an overview
Eddie Reed
The New England Journal of Medicine
|
September 8, 2006
ERCC1 measurements in clinical oncology
Eddie Reed
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2005
ERCC1 and clinical resistance to platinum-based therapy
Eddie Reed
The West Virginia Medical Journal
|
February 13, 2004
Breast and ovarian cancer genetics and prevention
Ramin Altaha, Eddie Reed, Jame Abraham
Oncology Reports
|
October 20, 2004
Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review)
Gangduo Wang, Eddie Reed, Qingdi Q Li
International Journal of Molecular Medicine
|
April 6, 2006
Protein phosphatase 2A interacts with Chk2 and regulates phosphorylation at Thr-68 after cisplatin treatment of human ovarian cancer cells
Xiaobing Liang, Eddie Reed, Jing Jie Yu
International Journal of Molecular Medicine
|
June 18, 2004
Apoptosis in prostate cancer: progressive and therapeutic implications (Review)
Gangduo Wang, Eddie Reed, Qingdi Q Li
Cancer Research
|
May 8, 2007
A Gynecologic Oncology Group study of platinum-DNA adducts and excision repair cross-complementation group 1 expression in optimal, stage III epithelial ovarian cancer treated with platinum-taxane chemotherapy
Kathleen M Darcy, Chunqiao Tian, Eddie Reed
Oncology Reports
|
June 14, 2014
Gli1 contributes to cellular resistance to cisplatin through altered cellular accumulation of the drug
Lauren Amable, Jason Fain, Elaine Gavin, et al.
Current Pharmaceutical Design
|
August 13, 2002
Epothilones: a novel class of non-taxane microtubule-stabilizing agents
Ramin Altaha, Tito Fojo, Eddie Reed, et al.
Page
of 9